In parallel, in the diagnostic technology landscape, aptamer immobilization to develop microfluidic devices and dynamic morphology studies using anti-EGFR aptamers seem to be very promising and practically applicable for GBM diagnosis [21,31]. Here, EGFR is linked to glioblastoma.